- Home
- AKRO vs FIVE Comparison
AKRO vs FIVE Comparison
Compare AKRO & FIVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AKRO
- FIVE
- Stock Information
- Founded
- AKRO 2017
- FIVE 2002
- Country
- AKRO United States
- FIVE United States
- Employees
- AKRO N/A
- FIVE N/A
- Industry
- AKRO Biotechnology: Pharmaceutical Preparations
- FIVE Department/Specialty Retail Stores
- Sector
- AKRO Health Care
- FIVE Consumer Discretionary
- Exchange
- AKRO Nasdaq
- FIVE Nasdaq
- Market Cap
- AKRO 2.8B
- FIVE 3.2B
- IPO Year
- AKRO 2019
- FIVE 2012
- Fundamental
- Price
- AKRO $39.85
- FIVE $85.25
- Analyst Decision
- AKRO Strong Buy
- FIVE Buy
- Analyst Count
- AKRO 9
- FIVE 19
- Target Price
- AKRO $76.29
- FIVE $95.24
- AVG Volume (30 Days)
- AKRO 1.1M
- FIVE 2.4M
- Earning Date
- AKRO 05-16-2025
- FIVE 06-04-2025
- Dividend Yield
- AKRO N/A
- FIVE N/A
- EPS Growth
- AKRO N/A
- FIVE N/A
- EPS
- AKRO N/A
- FIVE 4.60
- Revenue
- AKRO N/A
- FIVE $3,876,527,000.00
- Revenue This Year
- AKRO N/A
- FIVE $12.81
- Revenue Next Year
- AKRO N/A
- FIVE $9.56
- P/E Ratio
- AKRO N/A
- FIVE $18.70
- Revenue Growth
- AKRO N/A
- FIVE 8.91
- 52 Week Low
- AKRO $17.86
- FIVE $52.38
- 52 Week High
- AKRO $58.40
- FIVE $145.00
- Technical
- Relative Strength Index (RSI)
- AKRO 44.56
- FIVE 63.63
- Support Level
- AKRO $41.60
- FIVE $80.20
- Resistance Level
- AKRO $46.47
- FIVE $87.35
- Average True Range (ATR)
- AKRO 2.26
- FIVE 3.55
- MACD
- AKRO 0.08
- FIVE 1.63
- Stochastic Oscillator
- AKRO 21.84
- FIVE 88.95
About AKRO Akero Therapeutics Inc.
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis (MASH), or NASH, a disease without any approved therapies. The company's product candidate efruxifermin is an FGF21 analog with properties that have the potential to address the core processes underlying NASH pathogenesis.
About FIVE Five Below Inc.
Five Below Inc is a specialty value retailer offering merchandise targeted at the tween and teen demographic. The Company's edited assortment of products includes select brands and licensed merchandise. It derives revenue from sales of the Company's merchandise to customers.